Stay updated with breaking news from Protein Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bio-Techne Co. (NASDAQ:TECH – Get Rating) has earned an average rating of “Moderate Buy” from the twelve brokerages that are covering the firm, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average twelve-month target price among brokerages that […]
National Bank of Canada FI raised its holdings in shares of Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 3,001.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,621 shares of the biotechnology company’s stock after purchasing an additional 4,472 shares during the […]
Investing in vaccine manufacturing has both economic and societal benefits, in addition to protecting human health and limiting infection spread.
New York State Teachers Retirement System lifted its holdings in shares of Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 299.9% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 192,940 shares of the biotechnology company’s stock after buying an additional 144,691 shares during the period. New York State Teachers Retirement System’s holdings in Bio-Techne […]
Ellis Investment Partners LLC raised its stake in Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 300.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,416 shares of the biotechnology company’s stock after purchasing an additional 1,812 shares during the quarter. Ellis […]